Texas Permanent School Fund lifted its stake in Core Laboratories (NYSE:CLB – Get Rating) by 2.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 33,470 shares of the oil and gas company’s stock after acquiring an additional 662 shares during the quarter. Texas Permanent School Fund owned approximately 0.07% of Core Laboratories worth $663,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also modified their holdings of CLB. Citizens Financial Group Inc RI boosted its holdings in Core Laboratories by 96.3% in the second quarter. Citizens Financial Group Inc RI now owns 16,623 shares of the oil and gas company’s stock worth $329,000 after purchasing an additional 8,154 shares in the last quarter. State of New Jersey Common Pension Fund D bought a new stake in Core Laboratories in the second quarter worth $1,835,000. Northwestern Mutual Wealth Management Co. boosted its holdings in Core Laboratories by 103.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,537 shares of the oil and gas company’s stock worth $30,000 after purchasing an additional 780 shares in the last quarter. CIBC Private Wealth Group LLC boosted its holdings in Core Laboratories by 32.0% in the second quarter. CIBC Private Wealth Group LLC now owns 11,671 shares of the oil and gas company’s stock worth $231,000 after purchasing an additional 2,831 shares in the last quarter. Finally, Congress Asset Management Co. MA boosted its holdings in Core Laboratories by 19.1% in the second quarter. Congress Asset Management Co. MA now owns 508,129 shares of the oil and gas company’s stock worth $10,066,000 after purchasing an additional 81,359 shares in the last quarter. 98.22% of the stock is owned by institutional investors and hedge funds.
Core Laboratories Stock Down 5.7 %
NYSE CLB opened at $20.52 on Tuesday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.61 and a current ratio of 2.23. The firm has a 50-day simple moving average of $18.05 and a 200 day simple moving average of $19.56. Core Laboratories has a twelve month low of $13.19 and a twelve month high of $35.83. The stock has a market cap of $951.53 million, a PE ratio of 62.18, a PEG ratio of 1.24 and a beta of 2.63.
Core Laboratories Announces Dividend
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on the stock. StockNews.com initiated coverage on shares of Core Laboratories in a report on Wednesday, October 12th. They issued a “hold” rating for the company. Morgan Stanley cut shares of Core Laboratories from an “equal weight” rating to an “underweight” rating and set a $20.00 price target for the company. in a report on Monday, September 26th. Stifel Nicolaus decreased their price target on shares of Core Laboratories from $26.00 to $20.00 in a report on Tuesday, July 26th. Finally, Citigroup upgraded shares of Core Laboratories from a “sell” rating to a “neutral” rating and decreased their price target for the company from $24.00 to $17.00 in a report on Thursday, October 6th.
About Core Laboratories
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.
- Get a free copy of the StockNews.com research report on Core Laboratories (CLB)
- Three Ways To Win The Online Gambling Industry
- Santa Claus Rally? Here’s What Needs to Happen
- Is Ardelyx is A Buy After Slip in Early 2022
- Will the Return of Bob Iger Return the Magic to Disney Stock?
- Is Tesla A Bargain Now As It Trades At Two-Year Lows?
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.